CN205994861U - Intranasal medicator - Google Patents
Intranasal medicator Download PDFInfo
- Publication number
- CN205994861U CN205994861U CN201620557321.6U CN201620557321U CN205994861U CN 205994861 U CN205994861 U CN 205994861U CN 201620557321 U CN201620557321 U CN 201620557321U CN 205994861 U CN205994861 U CN 205994861U
- Authority
- CN
- China
- Prior art keywords
- catheter
- infusion administering
- head end
- tail end
- intranasal medicator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicinal Preparation (AREA)
Abstract
This utility model is related to technical field of medical instruments, more particularly, to a kind of intranasal medicator.This intranasal medicator, including：Infusion administering catheter, described infusion administering catheter has corresponding head end and tail end along its length；It is arranged on the shower nozzle of the head end of described infusion administering catheter, described shower nozzle is connected with described infusion administering catheter；The expanded capsule that can expand and shrink, is enclosed within outside described expanded capsule on head end and/or the described shower nozzle of described infusion administering catheter；And subsidiary conduit, described subsidiary conduit has corresponding head end and tail end along its length；The head end of described subsidiary conduit is connected with described expanded capsule.The purpose of this utility model is to provide intranasal medicator the effect so as to nasal-cavity administration and expansion nasal cavity, quickly to realize whole body and the local action of nasal-cavity administration.
Description
Technical field
This utility model is related to technical field of medical instruments, more particularly, to a kind of intranasal medicator.
Background technology
Nasal-cavity administration refers to via nasal cavity, plays a kind of administration side of whole body or local therapeutic effects through Nasal Mucosa Absorption
Formula.Nasal-cavity administration has whole body and the effect of two kinds of local：
1st, the general action of nasal-cavity administration：Nasal-cavity administration absorbs rapidly, gets final product onset within 3～5 minutes, reaches within 10 minutes about
Peak, easy to use, in case of emergency or compliance difference crowd such as children, nose administration seems particularly convenient quick.Cause
This, nasal-cavity administration be especially suitable for first aid, save oneself, children's premedicate.Progress up-to-date at present finds, nasal-cavity administration can be real
The important channel of existing brain-targeted drug delivery, research finds that, for systemic circulation administration, nasal-cavity administration is the side of this Noninvasive
Method can promptly by medicine through nasal mucosa cross-docking to brain and spinal cord, treat nervous system disease, and by whole body medicine
Thing exposed amount is near minimum.
2nd, the local action of nasal-cavity administration：Local is needed to answer in some medical care precesses of some surgery of nasal cavity or per nasal
With anesthetics and vasoconstrictor, to produce local anesthesia effect and to prevent bleeding from occurring, sometimes also need in this course
Carry out suitable nasal cavity to expand, to expose more spaces to operation or operation.
At present, clinically mostly via intranasal application administration is directly to instill medicinal liquid, enters by cotton swab infiltration or elbow syringe
Row administration, this administering mode is both uneven and inaccurate, and the ride number of patient is not high, and even medicinal liquid does not have sometimes
Act on nasal mucosal surface, but directly flow to pharynx rear wall or oral cavity from nasal meatus, this has been greatly reduced pharmaceutically-active timeliness
Property and the waste of medicinal liquid.
Based on this, the application is directed to the problems referred to above and provides a kind of intranasal medicator, makes it with nasal-cavity administration and expansion
Fill the effect of nasal cavity, thus quickly realizing whole body and the local action of above-mentioned nasal-cavity administration.
Utility model content
The purpose of this utility model is to provide intranasal medicator the work so as to nasal-cavity administration and expansion nasal cavity
With quickly to realize whole body and the local action of nasal-cavity administration.
The intranasal medicator that this utility model provides, including：
Infusion administering catheter, described infusion administering catheter has corresponding head end and tail end along its length；
It is arranged on the shower nozzle of the head end of described infusion administering catheter, described shower nozzle is connected with described infusion administering catheter；
The expanded capsule that can expand and shrink, is enclosed within head end and/or the institute of described infusion administering catheter outside described expanded capsule
State on shower nozzle；
And subsidiary conduit, described subsidiary conduit has corresponding head end and tail end along its length；Described auxiliary
The head end of conduit is connected with described expanded capsule.
Further, described expanded capsule includes outer wall and inwall, is enclosed within described inwall, described outer wall outside described outer wall
Form airtight exocoel with described inwall, described inwall forms airtight inner chamber；Described outer wall has multiple insecticide-spraying holes；
Described subsidiary conduit includes lumen catheter and outer cavities conduit pipe；
The head end of described lumen catheter and described inner space, so that described inwall expands or shrinks；
The head end of described outer cavities conduit pipe is connected with described exocoel, so that described outer wall expands or shrinks.
Further, described lumen catheter and described outer cavities conduit pipe are all installed in inside described infusion administering catheter；
Or, described infusion administering catheter, described lumen catheter and described outer cavities conduit pipe are all installed in inside conduit cortex.
Further, the material of described outer wall and described inwall is medical silica-gel.
Further, the tail end of described lumen catheter is provided with aerating device；
Described aerating device and described inner space, so that described inner chamber expands.
Further, described lumen catheter is provided with the first check valve, described first check valve is led near described inner chamber
The tail end of pipe；
It is additionally provided with air bleeding valve, described air bleeding valve is arranged at described first check valve and described inner chamber in described lumen catheter
Between the head end of conduit.
Further, the tail end of described outer cavities conduit pipe is provided with auxiliary chemicals dosing plant, described auxiliary chemicals dosing plant with described
Exocoel connects.
Further, described outer cavities conduit pipe is provided with the second check valve, described second check valve is led near described exocoel
The tail end of pipe.
Further, the tail end of described infusion administering catheter is provided with union joint.
Further, it is connected with the 3rd check valve between the tail end of described infusion administering catheter and described union joint；
Or, described infusion administering catheter be internally provided with the 3rd check valve.
The intranasal medicator that this utility model provides, including infusion administering catheter, by the shower nozzle of the head end of infusion administering catheter, with
Medicine is sprayed into nasal cavity, to realize nasal-cavity administration；By the expanded capsule that can expand and shrink, contraction state will be in
Expanded capsule and shower nozzle stretch into nasal cavity, expand, expand expanded capsule so that nasal cavity expands, and are sprayed by the mouth that sprays with making
Medicinal liquid be more evenly distributed in nasal cavity；The state that expanded capsule shrinks and expands is changed by subsidiary conduit, can be according to patient
The demand of own situation and operation selects the degree that expanded capsule expands.To sum up, this intranasal medicator is with nasal-cavity administration
With expand nasal cavity effect, quickly to realize whole body and the local action of nasal-cavity administration.
Brief description
In order to be illustrated more clearly that this utility model specific embodiment or technical scheme of the prior art, below will be right
In specific embodiment or description of the prior art the accompanying drawing of required use be briefly described it should be apparent that, below describe
In accompanying drawing be some embodiments of the present utility model, for those of ordinary skill in the art, do not paying creativeness
On the premise of work, other accompanying drawings can also be obtained according to these accompanying drawings.
The structural representation of the intranasal medicator that Fig. 1 provides for this utility model embodiment；
The structural representation of the expanded capsule of the intranasal medicator that Fig. 2 provides for this utility model embodiment.
Reference：
1- infusion administering catheter；2- shower nozzle；3- expanded capsule；
31- outer wall；311- exocoel；32- inwall；
321- inner chamber；4- subsidiary conduit；
41- lumen catheter；411- first check valve；412- air bleeding valve；
The outer cavities conduit pipe of 42-；421- second check valve；5- aerating device；
6- assists chemicals dosing plant；7- union joint；71- the 3rd check valve.
Specific embodiment
Below in conjunction with accompanying drawing, the technical solution of the utility model is clearly and completely described it is clear that described
Embodiment is a part of embodiment of this utility model, rather than whole embodiments.Based on the embodiment in this utility model, this
The every other embodiment that field those of ordinary skill is obtained under the premise of not making creative work, broadly falls into this practicality
Novel protected scope.
In description of the present utility model, " " center ", " on ", D score, "left", "right", " perpendicular it should be noted that term
Directly ", the orientation of instruction such as " level ", " interior ", " outward " or position relationship are based on orientation shown in the drawings or position relationship, are only
For the ease of description this utility model with simplify description, rather than instruction or the hint device of indication or element must have specific
Orientation, with specific azimuth configuration and operation, therefore it is not intended that to restriction of the present utility model.Additionally, term " the
One ", " second ", " the 3rd " are only used for describing purpose, and it is not intended that indicating or hint relative importance.
In description of the present utility model, it should be noted that unless otherwise clearly defined and limited, term " peace
Dress ", " being connected ", " connection " should be interpreted broadly, for example, it may be being fixedly connected or being detachably connected, or integratedly
Connect；Can be to be mechanically connected or electrically connect；Can be to be joined directly together it is also possible to be indirectly connected to by intermediary,
It can be the connection of two element internals.For the ordinary skill in the art, above-mentioned art can be understood with concrete condition
Concrete meaning in this utility model for the language.
Embodiment
Referring to shown in Fig. 1, Fig. 2, present embodiments providing a kind of intranasal medicator；Fig. 1 is this utility model embodiment
The structural representation of the intranasal medicator providing；The expansion of the intranasal medicator that Fig. 2 provides for this utility model embodiment
The structural representation of capsule, for clearer display structure, Fig. 2 is shown as sectional view.
Referring to shown in Fig. 1, Fig. 2, the intranasal medicator that the present embodiment provides, including：
Infusion administering catheter 1, infusion administering catheter 1 has corresponding head end and tail end along its length.
It is arranged on the shower nozzle 2 of the head end of infusion administering catheter 1, shower nozzle 2 is connected with infusion administering catheter 1；So that medicinal liquid can be by spray
2 carry out spray-type administration.
The expanded capsule 3 that can expand and shrink, is enclosed within head end and/or the shower nozzle 2 of infusion administering catheter 1 outside expanded capsule 3.
Preferably, it is enclosed within the head end of infusion administering catheter 1 outside expanded capsule 3；Or, outside expanded capsule 3, it is enclosed within the shower nozzle 2 of infusion administering catheter 1
On；Or, it is enclosed within the head end and shower nozzle 2 of infusion administering catheter 1 outside expanded capsule 3.Preferably, as shown in Fig. 2 outside expanded capsule 3
It is enclosed within the head end and shower nozzle 2 of infusion administering catheter 1, so that expanded capsule 3 preferably expands nasal cavity.Preferably, expanded capsule 3 has
Elasticity.
And subsidiary conduit 4, subsidiary conduit 4 has corresponding head end and tail end along its length；Subsidiary conduit 4
Head end is connected with expanded capsule 3.Namely the head end of subsidiary conduit 4 is near the head end of infusion administering catheter 1, the tail end of subsidiary conduit 4 leans on
The tail end of nearly infusion administering catheter 1.
Intranasal medicator described in the present embodiment, including infusion administering catheter 1, by the shower nozzle 2 of the head end of infusion administering catheter 1,
So that medicine is sprayed into nasal cavity, to realize nasal-cavity administration；By the expanded capsule 3 that can expand and shrink, will be in contraction-like
The expanded capsule 3 of state and shower nozzle 2 stretch into nasal cavity, expand, expand expanded capsule 3 so that nasal cavity expands, to make by the mouth that sprays
The medicinal liquid being sprayed is more evenly distributed in nasal cavity；The state that expanded capsule 3 shrinks and expands is changed by subsidiary conduit 4,
The degree of expanded capsule 3 expansion can be selected according to the demand of patient's own situation and operation.To sum up, this intranasal medicator has concurrently
There iss nasal-cavity administration and expand nasal cavity, quickly to realize whole body and the local action of nasal-cavity administration.
Further, expanded capsule 3 includes outer wall 31 and inwall 32, is enclosed within inwall 32 outside outer wall 31, outer wall 31 with interior
Wall 32 forms airtight exocoel 311, and inwall 32 forms airtight inner chamber 321；Outer wall 31 has multiple insecticide-spraying holes, and (in figure does not show
Show).Preferably, outer wall 31 and inwall 32 are respectively provided with elasticity.Preferably, multiple insecticide-spraying holes are evenly distributed on outer wall 31, so that
Medicinal liquid in outer wall 31 is uniformly sprayed at nasal cavity.
Subsidiary conduit 4 includes lumen catheter 41 and outer cavities conduit pipe 42.
The head end of lumen catheter 41 is connected with inner chamber 321, so that inwall 32 expands or shrinks.
The head end of outer cavities conduit pipe 42 is connected with exocoel 311, so that outer wall 31 expands or shrinks.By lumen catheter 41 with
Inner chamber 321 is made to inject gas, so that inwall 32 expands, thus expanding nasal cavity, will pass through the medicinal liquid of spray mouth sprinkling in nasal cavity
On be more evenly distributed；Meanwhile, outer wall 31 expands with inwall 32；By outer cavities conduit pipe 42 so that injecting hemorrhage etc. in exocoel 311
Medicinal liquid, the medicinal liquid such as hemorrhage is subject to inwall 32, the oppressing of outer wall 31, and sprays from insecticide-spraying hole, so that the medicine liquid spray such as hemorrhage exists
On the wall of nasal cavity.Expanded capsule 3 setting inner chamber 321 and exocoel 311, so that inner chamber 321 expands nasal cavity, exocoel 311 can spray
The medicinal liquid different from infusion administering catheter 1.For example, some have the patient of bleeding tendency, anticipate in nasal-cavity administration with during expanding
On the one hand external haemorrhage, now can make inner chamber 321 inflation expand nasal cavity, play the effect of hemostasis by compression；On the other hand can make
Exocoel 311 gives haemostatic medicament by insecticide-spraying hole, so that haemostatic medicament is uniformly sprayed onto at bleeding by the extruding of inner chamber 321, enters
One step improves the anthemorrhagic performance of described intranasal medicator；That is, described intranasal medicator passes through exocoel 311 and inner chamber 321,
Achieve to assist in compressing and give haemostatic medicament, its haemostatic effect is more preferable.
In the alternative of the present embodiment, infusion administering catheter 1, lumen catheter 41 and outer cavities conduit pipe 42 can be integrated into a pipe
Son or two or three pipes, for the ease of simplify intranasal medicator structure it is preferable that infusion administering catheter 1,
Lumen catheter 41 and outer cavities conduit pipe 42 are integrated into a pipe；Specifically, lumen catheter 41 and outer cavities conduit pipe 42 are all installed in
Inside infusion administering catheter 1；Or, infusion administering catheter 1, lumen catheter 41 and outer cavities conduit pipe 42 are all installed in inside conduit cortex.Pass through
The setting of infusion administering catheter 1, lumen catheter 41 and outer cavities conduit pipe 42 is integrated, in order to the application of intranasal medicator.Wherein lead
Pipe cortex is the outer layer of infusion administering catheter 1, lumen catheter 41 and outer cavities conduit pipe 42.
Further, the outer layer of infusion administering catheter 1 has steel wire floor, to increase the hardness of infusion administering catheter.
Alternatively, it is provided with steel wire floor in conduit cortex, infusion administering catheter 1, lumen catheter 41 and outer cavities conduit pipe 42 are all fixed
Inside steel wire floor；To increase the hardness of infusion administering catheter and conduit cortex.
In the alternative of the present embodiment, the material of outer wall 31 and inwall 32 for example can be moulded for silica gel, rubber, flexibility
Material；Preferably, the material of outer wall 31 and inwall 32 is medical silica-gel, by soft medical silica-gel, to increase relaxing of patient
Appropriateness and safety.
Alternatively, the material of subsidiary conduit 4 can be for example PVC, silica gel, rubber, plastics etc.；Preferably, subsidiary conduit 4
Material be medical PVC.
Alternatively, the material of infusion administering catheter 1 can be for example PVC, silica gel, rubber, plastics etc.；Preferably, infusion administering catheter 1
Material be medical PVC.
In the alternative of the present embodiment, the tail end of lumen catheter 41 is provided with aerating device 5；Aerating device 5 and inner chamber
321 connections, so that inner chamber 321 expands.Inflated to inner chamber 321 by lumen catheter 41 by aerating device 5, so that inner chamber
321 expansions, expand nasal cavity.
It should be noted that aerating device 5 can be manual aerating device；Such as aerating device 5 includes pressurization handss and pinches ball
(belonging to prior art, in figure does not show), pressurization handss are pinched ball and are connected by lumen catheter 41 with inner chamber 321.Pressurization handss pinch ball valency
Lattice are cheap, and the source of goods is more, it is possible to decrease the production cost of intranasal medicator.Pinching ball by the handss that pressurize can be easily and efficiently by sky
Gas is injected in the inner chamber 321 of expanded capsule 3.The material that pressurization handss pinch ball can be for example latex.
Aerating device 5 can also inflate otherwise to the inner chamber 321 of expanded capsule 3, for example, can pass through electrical pump
With electrified mode to expanded capsule 3 inner chamber 321 inflate, can also be by modes such as inflators in expanded capsule 3
Chamber 321 is inflated, or other modes are inflated to the inner chamber 321 of expanded capsule 3.
Further, lumen catheter 41 is provided with the first check valve 411, the first check valve 411 is near lumen catheter 41
Tail end；By the first check valve 411 so that the gas in lumen catheter 41 unidirectionally flows to inner chamber 321 from aerating device 5, keep away
Exempt from the back flow of gas that the factors such as source of the gas is unstable lead to, thus having ensured nasal cavity expansion to a certain extent.
Air bleeding valve 412 is additionally provided with lumen catheter 41, air bleeding valve 412 is arranged at the first check valve 411 and lumen catheter
Between 41 head end.So that after nasal-cavity administration terminates, the gas in inner chamber 321 is discharged by air bleeding valve 412, so that inner chamber 321
Shrink, consequently facilitating taking out intranasal medicator.
Preferably, air bleeding valve 412 is one-way exhaust valve, prevents gas from entering in lumen catheter 41 from air bleeding valve 412.
In the alternative of the present embodiment, the tail end of outer cavities conduit pipe 42 is provided with auxiliary chemicals dosing plant 6, assists chemicals dosing plant
6 are connected with exocoel 311.So that auxiliary chemicals dosing plant 6 is supplied to exocoel 311 by outer cavities conduit pipe 42, and some assist medicinal liquid, with
Auxiliary medicinal liquid is made to be sprayed on the wall of nasal cavity.For example pass through to assist chemicals dosing plant 6 to inject hemorrhage to exocoel 311, one can be made
The patient having bleeding tendency a bit, during nasal-cavity administration and expansion, once there is accidental haemorrhage, on the one hand can make inner chamber 321
The effect that nasal cavity plays hemostasis by compression is expanded in inflation, exocoel 311 on the other hand can be made to give haemostatic medicament in time and uniformly spray
To nasal cavity, to stop blooding further.
Second check valve 421 is provided with outer cavities conduit pipe 42, the second check valve 421 is near the tail end of outer cavities conduit pipe 42.Logical
Cross the second check valve 421 so that the medicinal liquid in outer cavities conduit pipe 42 unidirectionally flows to exocoel 311 from auxiliary chemicals dosing plant 6, to avoid
Medicinal liquid adverse current in outer cavities conduit pipe 42.
In the alternative of the present embodiment, the tail end of infusion administering catheter 1 is provided with union joint 7.By union joint 7 in order to defeated
Medicine conduit 1 connects loading apparatus, drug administration device etc..
Further, it is connected with the 3rd check valve 71 between the tail end of infusion administering catheter 1 and union joint 7；
Or, infusion administering catheter 1 be internally provided with the 3rd check valve 71.By the 3rd check valve 71 so that infusion administering catheter 1
Interior medicinal liquid unidirectionally flows to its head end from its tail end, to avoid the medicinal liquid adverse current in infusion administering catheter 1, reduces in infusion administering catheter 1
The pollution of medicinal liquid.
The intranasal medicator of the application ensure nasal-cavity administration basic function while, by expanding and shrink
Expanded capsule 3, innovated and transformed make its with expand nasal cavity function；Outer wall 31 He is had by expanded capsule 3
Inwall 32, makes the function more diversification of intranasal medicator, to meet the operation of the nasal cavities such as surgery of nasal cavity or nasal trachea cannula
When need nasal cavity to administer locally to the medicinal liquids such as anesthetics, hemorrhage and the suitable needs expanding nasal cavity.
The intranasal medicator of the application, the nasal cavity being provided with science expands air bag, i.e. expanded capsule 3, can pass through to fill
How much gas is realized adjusting the dynamics that expanded capsule 3 need to expand；The outer wall 31 being had by expanded capsule 3 and inwall 32, once
There is the situation of accidental haemorrhage, by injecting hemorrhage in exocoel 311, so that the insecticide-spraying hole that hemorrhage passes through outer wall 31 is uniformly sprayed
Go out, stop blooding in time.
Finally it should be noted that：Various embodiments above is only in order to illustrating the technical solution of the utility model, rather than it is limited
System；Although being described in detail to this utility model with reference to foregoing embodiments, those of ordinary skill in the art should
Understand：It still can be modified to the technical scheme described in foregoing embodiments, or to wherein some or all of
Technical characteristic carries out equivalent；And these modifications or replacement, do not make the essence of appropriate technical solution depart from this practicality new
The scope of type each embodiment technical scheme.
Claims (9)
1. a kind of intranasal medicator is it is characterised in that include：
Infusion administering catheter, described infusion administering catheter has corresponding head end and tail end along its length；
It is arranged on the shower nozzle of the head end of described infusion administering catheter, described shower nozzle is connected with described infusion administering catheter；
The expanded capsule that can expand and shrink, is enclosed within the head end of described infusion administering catheter and/or described spray outside described expanded capsule
On head；
And subsidiary conduit, described subsidiary conduit has corresponding head end and tail end along its length；Described subsidiary conduit
Head end connect with described expanded capsule；
Described expanded capsule includes outer wall and inwall, is enclosed within described inwall outside described outer wall, described outer wall and described inwall shape
Become airtight exocoel, described inwall forms airtight inner chamber；Described outer wall has multiple insecticide-spraying holes；
Described subsidiary conduit includes lumen catheter and outer cavities conduit pipe；
The head end of described lumen catheter and described inner space, so that described inwall expands or shrinks；
The head end of described outer cavities conduit pipe is connected with described exocoel, so that described outer wall expands or shrinks.
2. intranasal medicator according to claim 1 is it is characterised in that described lumen catheter and described outer cavities conduit pipe are equal
It is installed in inside described infusion administering catheter；
Or, described infusion administering catheter, described lumen catheter and described outer cavities conduit pipe are all installed in inside conduit cortex.
3. intranasal medicator according to claim 1 is it is characterised in that the material of described outer wall and described inwall is
Medical silica-gel.
4. intranasal medicator according to claim 1 is it is characterised in that the tail end of described lumen catheter is provided with inflation
Device；
Described aerating device and described inner space, so that described inner chamber expands.
5. intranasal medicator according to claim 4 is it is characterised in that to be provided with first in described lumen catheter unidirectional
Valve, described first check valve is near the tail end of described lumen catheter；
It is additionally provided with air bleeding valve, described air bleeding valve is arranged at described first check valve and described lumen catheter in described lumen catheter
Head end between.
6. intranasal medicator according to claim 1 is it is characterised in that the tail end of described outer cavities conduit pipe is provided with auxiliary
Chemicals dosing plant, described auxiliary chemicals dosing plant is connected with described exocoel.
7. intranasal medicator according to claim 6 is it is characterised in that to be provided with second on described outer cavities conduit pipe unidirectional
Valve, described second check valve is near the tail end of described outer cavities conduit pipe.
8. the intranasal medicator according to any one of claim 1-7 is it is characterised in that the tail end of described infusion administering catheter sets
It is equipped with union joint.
9. intranasal medicator according to claim 8 is it is characterised in that the tail end of described infusion administering catheter and described connection
It is connected with the 3rd check valve between head；
Or, described infusion administering catheter be internally provided with the 3rd check valve.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201620557321.6U CN205994861U (en) | 2016-06-08 | 2016-06-08 | Intranasal medicator |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201620557321.6U CN205994861U (en) | 2016-06-08 | 2016-06-08 | Intranasal medicator |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205994861U true CN205994861U (en) | 2017-03-08 |
Family
ID=58204497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201620557321.6U Expired - Fee Related CN205994861U (en) | 2016-06-08 | 2016-06-08 | Intranasal medicator |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205994861U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105999527A (en) * | 2016-06-08 | 2016-10-12 | 王存金 | Nasal drug delivery device |
-
2016
- 2016-06-08 CN CN201620557321.6U patent/CN205994861U/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105999527A (en) * | 2016-06-08 | 2016-10-12 | 王存金 | Nasal drug delivery device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105999527A (en) | Nasal drug delivery device | |
| CN110314273A (en) | A kind of supra-aural intranasal medicator and medication | |
| CN204972608U (en) | Trachea cannula | |
| US5540224A (en) | Drug Delivery port endotracheal tube | |
| CN205994861U (en) | Intranasal medicator | |
| CN111617358B (en) | Tracheal catheter capable of conducting airway surface anesthesia | |
| CN105193531A (en) | Nasal cavity supporting frame, nasal cavity supporting frame bracket and droplet jetting production method of nasal cavity supporting frame | |
| CN202490297U (en) | Double-cavity bronchial catheter capable of dosing continuously in airway | |
| CN110038209B (en) | Balloon dilation device for neurosurgery trigeminal nerve percutaneous treatment | |
| CN203280875U (en) | Trachea humidifying pump | |
| CN206081231U (en) | Ware of dosing sprays in disposable mouldable throat | |
| RU2739347C1 (en) | Endotracheal tube (versions) | |
| CN212491057U (en) | Tracheal catheter capable of performing airway surface anesthesia | |
| CN202289151U (en) | Tracheal tube with function of continuous infusion in trachea | |
| CN210096627U (en) | Trachea cannula drug administration device | |
| CN209392153U (en) | A kind of simple animal anesthetic ventilator | |
| CN112274747A (en) | Double-layer sac tracheal catheter | |
| CN207980140U (en) | A kind of clinic atomization anesthesia apparatus | |
| CN219783490U (en) | Nasal brain targeting drug delivery device | |
| CN211962767U (en) | Double-cavity bronchial catheter | |
| CN218685611U (en) | Double-layer sac tracheal catheter with medicine injection flow channel | |
| CN205903500U (en) | Two -chamber trachea cannula of area spraying pipe | |
| CN221771185U (en) | Multifunctional tracheal catheter | |
| CN213852593U (en) | Trachea cannula catheter | |
| CN214912137U (en) | Tracheal catheter for department of respiration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170308 Termination date: 20190608 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |